Dexamethasone Eye Implant and Insert and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Dexamethasone Eye Implant and Insert and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dexamethasone (intraocular), Dexamethasone (Ophthalmic)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexamethasone Eye Implant and Insert-Insulin glulisine
- Dexamethasone Eye Implant and Insert-Insulin Glulisine (Cartridges and Pens)
- Dexamethasone Eye Implant and Insert-Insulin Glulisine (Vials)
- Dexamethasone Eye Implant and Insert-Insulin glulisine Subcutaneous
- Dexamethasone Eye Implant and Insert-Insulin human inhaled Inhalation
- Dexamethasone Eye Implant and Insert-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Dexamethasone Eye Injection
- Insulin glargine, recombinant Subcutaneous-Dexamethasone injection
- Insulin glargine, recombinant Subcutaneous-Dexamethasone Injection Solution
- Insulin glargine, recombinant Subcutaneous-Dexamethasone Intensol
- Insulin glargine, recombinant Subcutaneous-Dexamethasone intraocular
- Insulin glargine, recombinant Subcutaneous-Dexamethasone ophthalmic